BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16620454)

  • 21. Effectiveness of cognitive-behavioral therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter study.
    Albert U; Aguglia A; Bogetto F; Cieri L; Daniele M; Maina G; Necci R; Parena A; Salvati L; Tundo A
    Psychother Psychosom; 2012; 81(6):383-5. PubMed ID: 22964775
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychosocial treatment for obsessive-compulsive disorder.
    Munford PR; Hand I; Liberman RP
    Psychiatry; 1994 May; 57(2):142-52. PubMed ID: 7938333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?
    Wheaton MG; Rosenfield D; Foa EB; Simpson HB
    J Consult Clin Psychol; 2015 Oct; 83(5):926-937. PubMed ID: 26009783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of CBT with fluoxetine works better for obsessive-compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP
    Asian J Psychiatr; 2012 Mar; 5(1):113. PubMed ID: 26878959
    [No Abstract]   [Full Text] [Related]  

  • 25. A review of antipsychotics in the treatment of obsessive compulsive disorder.
    Fineberg NA; Gale TM; Sivakumaran T
    J Psychopharmacol; 2006 Jan; 20(1):97-103. PubMed ID: 16204331
    [No Abstract]   [Full Text] [Related]  

  • 26. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
    Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors].
    Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M
    Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical practice. Obsessive-compulsive disorder.
    Jenike MA
    N Engl J Med; 2004 Jan; 350(3):259-65. PubMed ID: 14724305
    [No Abstract]   [Full Text] [Related]  

  • 29. A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation.
    Husted DS; Shapira NA
    CNS Spectr; 2004 Nov; 9(11):833-47. PubMed ID: 15520607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obsessive-compulsive disorder.
    Veale D; Roberts A
    BMJ; 2014 Apr; 348():g2183. PubMed ID: 24709802
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiobsessional effect of risperidone add-on treatment in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder may be dose-dependent.
    Ramasubbu R
    Arch Gen Psychiatry; 2002 May; 59(5):472; author reply 472-3. PubMed ID: 11982460
    [No Abstract]   [Full Text] [Related]  

  • 32. Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
    Friedman S; Abdallah TA; Oumaya M; Rouillon F; Guelfi JD
    J Clin Psychiatry; 2007 Jun; 68(6):972-3. PubMed ID: 17592930
    [No Abstract]   [Full Text] [Related]  

  • 33. [Again and again--the obsessive circle can be broken].
    Rück C; Andersson EM; Andréewitch S; Bejerot S; Ivarsson T; Bates S; Lindefors N
    Lakartidningen; 2011 Apr 6-12; 108(14):798-801. PubMed ID: 21638920
    [No Abstract]   [Full Text] [Related]  

  • 34. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
    Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M
    Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity.
    Brakoulias V
    Expert Opin Pharmacother; 2014 Jul; 15(10):1321-3. PubMed ID: 24866422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder].
    Vloet TD; Simons M; Herpertz-Dahlmann B
    Z Kinder Jugendpsychiatr Psychother; 2012 Jan; 40(1):29-39; quiz 39-40. PubMed ID: 22161940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2002 Jun; (7):896-905. PubMed ID: 12230713
    [No Abstract]   [Full Text] [Related]  

  • 38. [Obsessive-compulsive disorders: how to recognize and treat them].
    Walh K; Kordon A; Hohagen F
    MMW Fortschr Med; 2005 Sep; 147(35-36):42-5. PubMed ID: 16180571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obsessive-compulsive disorder and related conditions.
    Leonard HL; Freeman J; Garcia A; Garvey M; Snider L; Swedo SE
    Pediatr Ann; 2001 Mar; 30(3):154-60. PubMed ID: 11257945
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder.
    Kochan LD; Qureshi AI; Fallon BA
    Curr Psychiatry Rep; 2000 Aug; 2(4):327-34. PubMed ID: 11122977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.